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Letter to the Editor
A 60-year-old woman was admitted to the Department complaining 
of a slow growing mass in the right knee. Physical examination 
demonstrated a mass on the postero-lateral aspect of the right knee, 
which was not tender or mobile, however was rubbery and hard in 
consistency (Figure 1a). Full flexion and extension was observed 
without any restriction of joint movement. An ultrasound examination 
of the lesion showed an hyperechoic neoformation (48 × 21.6 × 43.7 
mm) well-defined. An magnetic resonance imaging (MRI) showed an 
expansive neoformation (43 × 21 mm) in contact with the superficial 
fascia. Subsequently, the patient underwent surgical resection of 
the lesion. Histological examination diagnosed undifferentiated 
pleomorphic sarcoma, high-grade with immunophenotypic aspects 
of muscle differentiation (strongly positive for vimentin  and smooth 
muscle actin  and focally and weakly positive for  S-100 protein but 
negative for CK AE1/AE3. The proliferation rate was estimated by Ki-
67 to be ~10%). The surgical resection marginal status was negative. 
Subsequently, the patient refused postoperative chemotherapy and 
radiation therapy. 
After five months, an 8 × 7 mm size tumor was observed on an MRI 
examination with contrast medium; this investigation was performed 
during outpatient follow-up. Under the diagnosis of recurrent 
undifferentiated pleomorphic sarcoma, the patient underwent surgical 
resection of the lesion. After surgery, the patient received adjuvant 
chemotherapy (three cycles of 90 mg/m2  epirubicin and 2500 mg/
m2 ifosfamide every 3 weeks) and radiotherapy. Radiotherapy was given 
daily with a total dose of 60 Gy at 2.0 Gy per fraction, five days per week. 
Two months after the end of radiotherapy, she attended our 
outpatient dermatologic clinic due to the appearance of cutaneous 
painful and ulcerated lesions on the irradiated site of the right knee.
Physical examination revealed a warm pruritic erythematous 
area of about 10 × 15 (Figure 1b). The patients was treated with 
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LED irradiation and polyurethane foam with remarkable improvement 
of the skin lesions (Figure 2a and 2b).
Radiotherapy is used to limit the growth of neoplastic cells. Because 
radiotherapy exposes healthy cells within the vicinity of tumors 
and between the tumor site and the radiation source to radiation, 
undesirable sequelae often are unavoidable [1].
The reactions are a result of radiation treatment disrupting the 
normal process of cell division and regeneration, resulting in cell 
damage or cell death [2]. Damage is usually most prominent in tissues 
with rapid rates of proliferation, such as skin, mucosa, and bone 
marrow. Acute  radiation-induced skin reactions range from mild 
erythema, dry and moist desquamation, to ulceration, as a result of 
injury to the epithelium and underlying structures. Late toxicity can 
include telangiectasia, edema, ulceration, atrophy and fibrosis and 
typically is defined as changes occurring beyond 90 days of treatment 
[3,4]. The factors influencing the development or severity of radiation-
induced skin reactions are intrinsic (age, general health, ethnic origin, 
coexisting diseases, UV exposure, hormonal status, and genetic factors) 
and extrinsic: (dose, volume and fraction of radiation, radio-sensitisers, 
concurrent chemotherapy, and the site of treatment [1]. Radiation-
induced skin reactions have an impact on the level of pain/discomfort 
experienced and the quality of life of those who undergo radiation 
 
Figure 1: (a) postero-lateral aspect of the right knee, (b) warm pruritic 
erythematous area 
 
Figure 2: Remarkable improvement of the skin lesions.
Citation: Lisi R, Miraglia E, Cantisani C, Giustini S, Paolino G, et al. (2015) Skin Toxicity after Radiotherapy: About a Case. Biochem Anal Biochem 4: 195. 
doi:10.4172/2161-1009.1000195
Volume 4 • Issue 3 • 1000195Biochem Anal BiochemISSN: 2161-1009 Biochem, an open access journal 
Page 2 of 2
treatment. Critical analysis of the evidence of clinical interventions 
available for the prevention and treatment of acute radiation injury 
demonstrate the lack of objective data. To date, universally accepted 
guidelines for the management of radiotherapy-induced skin injuries 
do not exist. Interventions can be generally viewed as either preventive 
or management strategies. Preventive strategies may include: void the 
use of metallic-based topical products (zinc oxide creams or deodorants 
with an aluminum base, for instance), because they may increase the 
surface dose to skin, wear loose-fitting clothing over the irradiated area to 
prevent friction injuries, maintain a clean and dry irradiated area, avoid 
extreme temperatures and the use of starch-based products because 
they increase the risk of infection. Management strategies may include 
active management of any erythema, desquamation and ulceration of 
the skin, with topical preparations and dressings [1]. We report the 
case of a woman who developed radiotherapy-induced skin reactions 
and we underline the importance of dermatological periodic visits to 
prevent these complications.
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